These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6301579)
1. Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair. Di Minno G; Capitanio AM; Thiagarajan P; Martinez J; Murphy S Blood; 1983 Jun; 61(6):1054-9. PubMed ID: 6301579 [TBL] [Abstract][Full Text] [Related]
2. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929 [TBL] [Abstract][Full Text] [Related]
3. Exposure of fibrinogen-binding sites on stored platelets on stimulation by aggregating agents--an electron microscopic study. Kitajima H; Takayama S; Yasunaga K Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):93-101. PubMed ID: 2741653 [TBL] [Abstract][Full Text] [Related]
4. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin. Peerschke EI Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566 [TBL] [Abstract][Full Text] [Related]
5. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111 [TBL] [Abstract][Full Text] [Related]
6. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions. Oliver JA; Albrecht RM Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571 [TBL] [Abstract][Full Text] [Related]
7. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation. Peerschke EI J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399 [TBL] [Abstract][Full Text] [Related]
8. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP. Plow EF; Marguerie GA J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495 [TBL] [Abstract][Full Text] [Related]
9. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130 [TBL] [Abstract][Full Text] [Related]
10. Epinephrine-induced aggregation of rabbit platelets refractory to ADP. Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167 [TBL] [Abstract][Full Text] [Related]
11. Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine. Shattil SJ; Motulsky HJ; Insel PA; Flaherty L; Brass LF Blood; 1986 Dec; 68(6):1224-31. PubMed ID: 3779100 [TBL] [Abstract][Full Text] [Related]
12. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. Coller BS J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335 [TBL] [Abstract][Full Text] [Related]
13. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Shattil SJ; Budzynski A; Scrutton MC Blood; 1989 Jan; 73(1):150-8. PubMed ID: 2535942 [TBL] [Abstract][Full Text] [Related]
14. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. Shattil SJ; Hoxie JA; Cunningham M; Brass LF J Biol Chem; 1985 Sep; 260(20):11107-14. PubMed ID: 2411729 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680 [TBL] [Abstract][Full Text] [Related]
16. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302 [TBL] [Abstract][Full Text] [Related]
17. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies. McEver RP; Bennett EM; Martin MN J Biol Chem; 1983 Apr; 258(8):5269-75. PubMed ID: 6220015 [TBL] [Abstract][Full Text] [Related]
18. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123). Kornecki E; Lee H; Merlin F; Hershock D; Tuszynski GP; Niewiarowski S Thromb Res; 1984 Apr; 34(1):35-49. PubMed ID: 6328693 [TBL] [Abstract][Full Text] [Related]
19. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Huang TF; Liu CZ; Ouyang CH; Teng CM Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330 [TBL] [Abstract][Full Text] [Related]
20. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa. Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]